VYGR
Voyager Therapeutics, Inc. - Common Stock (VYGR)
$72
About Voyager Therapeutics, Inc. - Common Stock (VYGR)
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Details
Daily high
$1.88
Daily low
$1.68
Price at open
--
52 Week High
$5.48
52 Week Low
$1.68
Market cap
115.2M
Dividend yield
-
Volume
404
Avg. volume
1.0M
P/E ratio
-1.03
Voyager Therapeutics, Inc. - Common Stock News
Details
Daily high
$1.88
Daily low
$1.68
Price at open
--
52 Week High
$5.48
52 Week Low
$1.68
Market cap
115.2M
Dividend yield
-
Volume
404
Avg. volume
1.0M
P/E ratio
-1.03